<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02885857</url>
  </required_header>
  <id_info>
    <org_study_id>S2015-023-02</org_study_id>
    <nct_id>NCT02885857</nct_id>
  </id_info>
  <brief_title>Safety and Efficacy of Shenyankangfu Tablets for Chronic Kidney Disease</brief_title>
  <official_title>Safety and Efficacy of Shenyankangfu Tablets for Chronic Kidney Disease</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Chen Xiangmei</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Tianjin TongRenTang Group Co., Ltd.</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Chinese PLA General Hospital</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Safety and efficacy of long-term application of Shenyankangfu Tablets in Large sample of
      patients with chronic kidney disease.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Research purpose: Safety and efficacy of long-term application of Shenyankangfu Tablets in
      Large sample of patients with chronic kidney disease.

      The crowd: patients with primary glomerular nephritis, diabetic nephropathy patients.

      Study design: a multicenter clinical study design, openness. The study drug: Shenyan Kangfu
      Tablets. Statistical analysis: Research plan is determined, by statistical professionals
      responsible for negotiation with the principal investigator for statistical analysis plan.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>June 2015</start_date>
  <completion_date type="Anticipated">December 2016</completion_date>
  <primary_completion_date type="Anticipated">December 2016</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>24-hour urinary protein excretion</measure>
    <time_frame>Observation time: 24 weeks.Tested once every 12 weeks, it was detected three times</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Serum creatinine</measure>
    <time_frame>Observation time: 24 weeks.Tested once every 12 weeks, it was detected three times</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Glomerular filtration rate</measure>
    <time_frame>Observation time: 24 weeks.Tested once every 12 weeks, it was detected three times</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Albumin</measure>
    <time_frame>Observation time: 24 weeks.Tested once every 12 weeks, it was detected three times</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Glycated hemoglobin</measure>
    <time_frame>Observation time: 24 weeks.Tested once every 24 weeks, were detected in 2 times</time_frame>
    <description>Observations of the project value and the percentage change in value before and after the treatment.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Symptom scores</measure>
    <time_frame>Observation time: 24 weeks.Tested once every 12 weeks, it was detected three times</time_frame>
  </secondary_outcome>
  <other_outcome>
    <measure>Routine blood test</measure>
    <time_frame>Observation time: 24 weeks.Tested once every 12 weeks, it was detected three times</time_frame>
  </other_outcome>
  <other_outcome>
    <measure>Routine urine test</measure>
    <time_frame>Observation time: 24 weeks.Tested once every 12 weeks, it was detected three times</time_frame>
  </other_outcome>
  <other_outcome>
    <measure>Liver function</measure>
    <time_frame>Observation time: 24 weeks.Tested once every 12 weeks, it was detected three times</time_frame>
  </other_outcome>
  <other_outcome>
    <measure>Renal function tests</measure>
    <time_frame>Observation time: 24 weeks.Tested once every 12 weeks, it was detected three times</time_frame>
  </other_outcome>
  <other_outcome>
    <measure>Potassium detection</measure>
    <time_frame>Observation time: 24 weeks.Tested once every 12 weeks, it was detected three times</time_frame>
  </other_outcome>
  <other_outcome>
    <measure>blood glucose testing</measure>
    <time_frame>Observation time: 24 weeks.Tested once every 12 weeks, it was detected three times</time_frame>
  </other_outcome>
  <other_outcome>
    <measure>Electrocardiograph</measure>
    <time_frame>Observation time: 24 weeks.Tested once every 24 weeks, were detected in 2 times</time_frame>
  </other_outcome>
  <other_outcome>
    <measure>chest radiography</measure>
    <time_frame>Observation time: 24 weeks.Tested once every 24 weeks, were detected in 2 times</time_frame>
  </other_outcome>
  <other_outcome>
    <measure>Adverse events / adverse reactions</measure>
    <time_frame>Observation time: 24 weeks.Tested once every 24 weeks, were detected in 2 times</time_frame>
    <description>Follow-up 3 times.Subject at any time to contact your doctor.</description>
  </other_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">1500</enrollment>
  <condition>Chronic Kidney Disease</condition>
  <arm_group>
    <arm_group_label>Shenyan kangfu Tablets</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Shenyan Kangfu Tablets；Each weighing 0.48g；Oral；Once five, three times a day</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Shenyan Kangfu Tablet</intervention_name>
    <description>Observation period: 24 weeks. The dosage regimen: each piece weighs 0.48 g. 5 / time, 3 times daily, orally after dinner.</description>
    <arm_group_label>Shenyan kangfu Tablets</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Diagnosed with primary glomerulonephritis or diabetic nephropathy;

          2. Aged from 18 to 70 years，male or female

          3. GFR≥45ml/min/1.73㎡

          4. 0.5g≤24 hours proteinuria≤3.0g

          5. glycated hemoglobin (HbAlc) ≤8% (This has been limited to patients with diabetic
             nephropathy)

          6. Traditional Chinese medicine syndrome conform Qi-Yin Deficiency

          7. Obtain the agreement of patients or their guardians, and signed informed consent file

        Exclusion Criteria:

          1. Secondary nephropathy

          2. People allergic to Shenyankangfu tables

          3. Combined with severe primary disease of heart, brain, liver and hematopoietic system,
             or other serious diseases can affect patient's life

          4. Pregnant or lactating women

          5. Be participating in another clinical study at the same period
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>YongLi Zhan, investigator</last_name>
    <role>Principal Investigator</role>
    <affiliation>Guang'anmen Hospital of China Academy of Chinese Medical Sciences</affiliation>
  </overall_official>
  <overall_official>
    <last_name>HongTao Yang, investigator</last_name>
    <role>Principal Investigator</role>
    <affiliation>First Teaching Hospital of Tianjin University of Traditional Chinese Medicine</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Meng Liang, investigator</last_name>
    <role>Principal Investigator</role>
    <affiliation>174th hospital of the People's Liberation Army</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Lu Ma, investigator</last_name>
    <role>Principal Investigator</role>
    <affiliation>Beidaihe Sanatorium of Beijing Military Mrca</affiliation>
  </overall_official>
  <overall_official>
    <last_name>LiQun Song, investigator</last_name>
    <role>Principal Investigator</role>
    <affiliation>Heilongjiang University of Chinese Medicine</affiliation>
  </overall_official>
  <overall_official>
    <last_name>QiaoLing Zhou, investigator</last_name>
    <role>Principal Investigator</role>
    <affiliation>Xiangya Hospital of Central South University</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Ping Luo, investigator</last_name>
    <role>Principal Investigator</role>
    <affiliation>Second Hospital of Jilin University</affiliation>
  </overall_official>
  <overall_official>
    <last_name>RongShan Li, investigator</last_name>
    <role>Principal Investigator</role>
    <affiliation>Shanxi provincial peple's hospital</affiliation>
  </overall_official>
  <overall_official>
    <last_name>XiaoHong Cheng, investigator</last_name>
    <role>Principal Investigator</role>
    <affiliation>Shaanxi Traditional Chinese Medicine Hospital</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Jie Wu, investigator</last_name>
    <role>Principal Investigator</role>
    <affiliation>Chinese PLA General Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Jie Wu, chaieman</last_name>
    <phone>18210128683</phone>
    <email>wujie301@126.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>SiJi Li, director</last_name>
    <phone>13821669488</phone>
    <email>miaoshujie@yeah.net</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>National Clinical Research Center for Kidney Disease, State Key Laboratory of Kidney Disease, Department of Nephrology, Chinese PLA General Hospital</name>
      <address>
        <city>Beijing</city>
        <state>Beijing</state>
        <zip>100853</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>jie wu, doctor</last_name>
      <email>wujie301@163.com</email>
    </contact>
    <investigator>
      <last_name>xiangmei chen, doctor</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Guang'anmen Hospital, China Academy of Chinese Medical Sciences</name>
      <address>
        <city>Beijing</city>
        <state>Beijing</state>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Daping Hospital,Research Institute of Surgery Third Military Medical University</name>
      <address>
        <city>Chongqing</city>
        <state>Chongqing</state>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Fuzhou General Hospital Nanjing Military Command</name>
      <address>
        <city>Fuzhou</city>
        <state>Fujian</state>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>174th hospital of the People's Liberation Army</name>
      <address>
        <city>Xiamen</city>
        <state>Fujian</state>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Beidaihe Sanatorium of Beijing Military Mrca</name>
      <address>
        <city>Qinhuangdao</city>
        <state>Hebei</state>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Heilongjiang University of Chinese Medicine</name>
      <address>
        <city>Harbin</city>
        <state>Heilongjiang</state>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Henan Provincial People'S Hospital</name>
      <address>
        <city>Zhengzhou</city>
        <state>Henan</state>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Shandong Province Hospital</name>
      <address>
        <city>Jinan</city>
        <state>Shandong</state>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Changhai Hospital of Shanghai</name>
      <address>
        <city>Shanghai</city>
        <state>Shanghai</state>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>LONGHUA Hospital Shanghai University of TCM</name>
      <address>
        <city>Shanghai</city>
        <state>Shanghai</state>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>First Hospital of Shanxi Medical University</name>
      <address>
        <city>Taiyuan</city>
        <state>Shanxi</state>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>First Teaching Hospital of Tianjin University of TCM</name>
      <address>
        <city>Tianjin</city>
        <state>Tianjin</state>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>August 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>June 3, 2015</study_first_submitted>
  <study_first_submitted_qc>August 26, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 1, 2016</study_first_posted>
  <last_update_submitted>August 26, 2016</last_update_submitted>
  <last_update_submitted_qc>August 26, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">September 1, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>Chinese PLA General Hospital</investigator_affiliation>
    <investigator_full_name>Chen Xiangmei</investigator_full_name>
    <investigator_title>professor</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Kidney Diseases</mesh_term>
    <mesh_term>Renal Insufficiency, Chronic</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

